Effect of cessation of drug misuse on the immune status of HIV-infected injecting drug users

被引:0
|
作者
Radkowski, M
Werezynska, T
Laskus, T
Kaminska, E
Kuligowski, S
机构
[1] INST INFECT & PARASIT DIS, WARSAW, POLAND
[2] CTR AIDS DIAG & THERAPY, WARSAW, POLAND
[3] NOWOWIEJSKI HOSP, REG DETOXIFICAT CTR, WARSAW, POLAND
[4] UNIV PITTSBURGH, MED CTR, PITTSBURGH, PA USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of cessation of i.v. drug use on CD4 lymphocyte count and serum levels of beta(2)-microglobulin (beta(2)m) and soluble interleukin-2 receptor (sIL-2R) were prospectively investigated in 41 HIV-positive drug users enrolled in a methadone treatment programme. Fifteen HIV-positive matched non-abstainers served as controls. During the follow-up of 12 months the mean CD4 lymphocyte count remained unchanged in the methadone-treated group but fell significantly in controls. beta(2)m and sIL-2R values decreased in abstainers at the beginning of the treatment but rose in non-abstaining group. We conclude that cessation of illicit drug abuse and methadone treatment in HIV-infected injecting drug users may exert a beneficial effect on the immune status.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 50 条
  • [1] Drug injection cessation among HIV-infected injecting drug users
    Bouhnik, AD
    Carrieri, MP
    Rey, D
    Spire, B
    Gastaut, JA
    Gallais, H
    Obadia, Y
    [J]. ADDICTIVE BEHAVIORS, 2004, 29 (06) : 1189 - 1197
  • [2] Inflammatory and immune mediators in crevicular fluid from HIV-infected injecting drug users
    Grbic, JT
    Lamster, IB
    MitchellLewis, D
    [J]. JOURNAL OF PERIODONTOLOGY, 1997, 68 (03) : 249 - 255
  • [3] Serial position effects in HIV-infected injecting drug users
    Waldrop, D
    Ownby, RL
    Kumar, M
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2004, 114 (04) : 493 - 516
  • [4] Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy
    Tang, AM
    Smit, E
    Semba, RD
    Shah, N
    Lyles, CM
    Li, DG
    Vlahov, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (04): : 321 - 326
  • [5] Quality of life of HIV-infected injecting drug users in the era of HAART
    Surah, S.
    McLaughlin, J.
    Synott, C.
    Lee, S.
    Storeng, C.
    Keating, S.
    O'Dea, S.
    Adams, R.
    Keenan, E.
    Barry, M.
    Mulcahy, F.
    Walsh, C.
    Lyons, F.
    [J]. HIV MEDICINE, 2014, 15 : 66 - 66
  • [6] Nonadherence among HIV-Infected injecting drug users: The impact of social instability
    Bouhnik, AD
    Chesney, M
    Carrieri, P
    Gallais, H
    Moreau, J
    Moatti, JP
    Obadia, Y
    Spire, B
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 : S149 - S153
  • [7] Can we reduce the burden of morbidity in HIV-infected injecting drug users?
    Selwyn, PA
    [J]. AIDS, 1996, 10 (12) : 1429 - 1430
  • [8] Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment
    Moatti, JP
    Carrieri, MP
    Spire, B
    Gastaut, JA
    Cassuto, JP
    Moreau, J
    [J]. AIDS, 2000, 14 (02) : 151 - 155
  • [9] Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users
    Mann, B.
    Milloy, M-J
    Kerr, T.
    Zhang, R.
    Montaner, J.
    Wood, E.
    [J]. HIV MEDICINE, 2012, 13 (10) : 596 - 601
  • [10] Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users
    Carrieri, MP
    Rey, D
    Loundou, A
    Lepeu, G
    Sobel, A
    Obadia, Y
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2003, 72 (01) : 13 - 21